Abstract
Background
Acromegaly is a rare disease caused by an excess of growth hormone and insulin-like growth factor 1. It is usually diagnosed because of typical signs such as macroglossia, acral enlargement, jaw prognathism and malocclusion. Systemic complications are a major cause of morbidity and mortality in acromegaly, and many patients remain undiagnosed for several years. Increased ultrasound (US) application in the general population, and including among acromegaly patients, has revealed many suggestive features which, taken together with clinical suspicion, could induce suspicion of this disease.
Purpose
This review describes main US features in acromegaly. Echocardiography shows a typical cardiomyopathy, characterized by left ventricular hypertrophy, diastolic and systolic dysfunction, aortic and mitral regurgitation, and increased aortic root diameters. US preclinical markers of atherosclerosis, such as intima media thickness (IMT), seem also to be impaired. Visceromegaly and increased organ stiffness are other features of acromegaly, including enlarged prostate, kidneys, liver, and thyroid. In addition, other US findings are: renal cysts, micronephrolithiasis, impairment of renal haemodynamic parameters, gallstones and gallbladder polyps, hepatic steatosis, thyroid nodules, multinodular goiter, and polycystic ovaries. Musculoskeletal US findings are increased cartilage thickness, impaired density and elasticity of bones, nerve enlargement, carpal and cubital tunnel syndrome, and trigger finger.
Conclusions
Acromegaly patients frequently present systemic complications and a diagnostic delay. US features of acromegaly are not specific, but could potentially have a key role in early detection of the disease in the presence of typical clinical features.
Similar content being viewed by others
Abbreviations
- US:
-
Ultrasound
- GH:
-
Growth hormone
- IGF-1:
-
Insulin-like growth factor
- ACRO:
-
Acromegaly patients
- LVH:
-
Left ventricular hypertrophy
- IMT:
-
Carotid intima media thickness
- PWV:
-
Pulse wave velocity
- FMD:
-
Flow-mediated dilation
- RRI:
-
Renal resistive index
- PCOS:
-
Polycystic ovary syndrome
- ACRO-cats:
-
Cats with acromegaly
References
Melmed S (2006) Acromegaly. N Engl J Med 355:2558–2573
Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Von Werder K, Melmed S (2000) Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85(2):526–529
Melmed S, Colao A, Barkan A, Molitch M, Grossman AB, Kleinberg D, Clemmons D, Chanson P, Laws E, Schlechte J, Vance ML, Ho K, Giustina A, Acromegaly Consensus Group (2009) Guidelines for acromegaly management: an update. J Clin Endocrinol Metab 94(5):1509–1517
Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A, Wass JA, Endocrine Society (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933–3951
Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25(1):102–152
Gadelha MR, Kasuki L, Lim DST, Fleseriu M (2019) Systemic complications of acromegaly and the impact of the current treatment landscape: an update. Endocr Rev 40(1):268–332. https://doi.org/10.1210/er.2018-00115
Bolfi F, Neves AF, Boguszewski CL, Nunes-Nogueira VS (2018) Mortality in acromegaly decreased in the last decade: a systematic review and meta-analysis. Eur J Endocrinol 179(1):59–71
Aydin K, Cınar N, Dagdelen S, Erbas T (2014) Diagnosis of acromegaly: role of the internist and the other medical professionals. Eur J Intern Med 25(2):e25–e26
Popielarz-Grygalewicz A, Gąsior JS, Konwicka A, Grygalewicz P, Stelmachowska-Banaś M, Zgliczyński W, Dąbrowski M (2018) Heart in acromegaly: the echocardiographic characteristics of patients diagnosed with acromegaly in various stages of the disease. Int J Endocrinol 11(2018):6935054
Bankir M, Sumbul HE, Koc AS, Demirtas D, Acibucu F (2019) Elastography detected solid organ stiffness increased in patients with acromegaly. Medicine (Baltimore) 98(3):e14212
Boguszewski CL, Ayuk J (2016) Management of endocrine disease: acromegaly and cancer: an old debate revisited. Eur J Endocrinol 175(4):R147–R156
Tirosh A, Shimon I (2017) Complications of acromegaly: thyroid and colon. Pituitary 20(1):70–75
Gasperi M, Martino E, Manetti L, Arosio M, Porretti S, Faglia G, Mariotti S, Colao AM, Combardi G, Baldelli R, Camanni F, Liuzzi A, Acromegaly Study Group of the Italian Society of Endocrinology (2002) Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study. J Endocrinol Investig 25(3):240–245
Kumar S, Yadav RN, Gupta P, Gaspar BL, Kakkar N, Verma A, Parthan G, Bhansali A, Mukherjee KK, Korbonits M, Dutta P (2015) Prostatic hyperplasia in acromegaly, a myth or reality: a case-control study. Eur J Endocrinol 173(2):X1
Goto J, Otsuka F, Inagaki K, Tsukamoto N, Suzuki J, Miyoshi T, Ogura T, Kamada Y, Makino H (2009) Effects of growth hormone reduction in a patient with polycystic ovary syndrome complicated with acromegaly. Endocr J56(1):157–160
Hashimoto S, Yatabe J, Midorikawa S, Sanada H, Watanabe T (2003) Inhibition of growth hormone excess reduces insulin resistance and ovarian dysfunction in a lean case of polycystic ovary syndrome with a growth-hormone-producing pituitary adenoma. Horm Res 59(3):149–155
Katznelson L, Atkinson JL, Cook DM, Ezzat SZ, Hamrahian AH, Miller KK, American Association of Clinical Endocrinologists (2011) American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly—2011 update. Endocr Pract 17(Suppl 4):1–44
Melmed S, Casanueva FF, Klibanski A, Bronstein MD, Chanson P, Lamberts SW, StrasburgerCJ Wass JA, Giustina A (2013) A consensus on the diagnosis and treatment of acromegaly complications. Pituitary 16(3):294–302
Sharma AN, Tan M, Amsterdam EA, Singh GD (2018) Acromegalic cardiomyopathy: epidemiology, diagnosis, and management. Clin Cardiol 1(3):419–425
Viani S, Zucchelli G, Paperini L, Soldati E, Segreti L, Di Cori A, Menichetti F, Coluccia G, Andreini D, Branchitta G, Bongiorni MG (2016) subcutaneous implantable defibrillator in an acromegalic pregnant woman for secondary prevention of sudden cardiac death: when (2) technologies save (2) lives. Int J Cardiol 223:313–315
An Z, He YQ, Liu GH, Ge LL, Zhang WQ (2015) Malignant ventricular tachycardia in acromegaly: a case report. Sao Paulo Med J133(1):55–59
Maione L, Brue T, Beckers A, Delemer B, Petrossians P, Borson-Chazot F, Chabre O, François P, Bertherat J, Cortet-Rudelli C, Chanson P, French Acromegaly Registry Group (2017) Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry. Eur J Endocrinol 176(5):645–655
Bihan H, Espinosa C, Valdes-Socin H, Salenave S, Young J, Levasseur S, Assayag P, Beckers A, Chanson P (2004) Long-term outcome of patients with acromegaly and congestive heart failure. J Clin Endocrinol Metab 89(11):5308–5313
Di Bello V, Bogazzi F, Di Cori A, Palagi C, Delle Donne MG, Gavioli S, Talini E, Cosci C, Sardella C, Tonti G, Martino E, Balbarini A, Mariani M (2006) Myocardialsystolicstrainabnormalities in patients with acromegaly: a prospective color Doppler imaging study. J Endocrinol Investig 29(6):544–550
Volschan ICM, Kasuki L, Silva CMS, Alcantara ML, Saraiva RM, Xavier SS, Gadelha MR (2017) Two dimensional speckle tracking echocardiography demonstrates no effect of active acromegaly on left ventricular strain. Pituitary 20(3):349–357
Popielarz-Grygalewicz A, Gąsior JS, Konwicka A, Grygalewicz P, Stelmachowska-Banaś M, Zgliczyński W, Dąbrowski M (2018) Heart in acromegaly: the echocardiographic characteristics of patients diagnosed with acromegaly in various stages of the disease. Int J Endocrinol 2018:1–7
Colao A, Vitale G, Pivonello R, Ciccarelli A, Di Somma C, Lombardi G (2004) The heart: an end-organ of GH action. Eur J Endocrinol 151(Suppl 1):S93–S101
Dargad RR, Parekh JD, Dargad RR (2016) Acromegaly with dilated cardiomyopathy. J Assoc Physicians India 64(6):96–97
Sue M, Yoshihara A, Okubo Y, Ishikawa M, Ando Y, Hiroi N, Shibuya K, Yoshino G (2010) A case of juvenile acromegaly that was initially diagnosed as severe congestive heart failure from acromegaly-induced dilated cardiomyopathy. Intern Med 49(19):2117–2121
Pivonello R, Auriemma RS, Grasso LF, Pivonello C, Simeoli C, Patalano R, Galdiero M, Colao A (2017) Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities. Pituitary 20:46–62
Pereira AM, van Thiel SW, Lindner JR, Roelfsema F, van der Wall EE, Morreau H, Smit JW, Romijn JA, Bax JJ (2004) Increased prevalence of regurgitant valvular heart disease in acromegaly. J Clin Endocrinol Metab 89:71–75
Van der Klaauw AA, Bax JJ, Roelfsema F, Bleeker GB, Holman ER, Corssmit EP, van der Wall EE, Smit JW, Romijn JA, Pereira AM (2006) Uncontrolled acromegaly is associated with progressive mitral valvular regurgitation. Growth Horm IGF Res 16(2):101–107
Van der Klaauw AA, Bax JJ, Smit JW, Holman ER, Delgado V, Bleeker GB, Biermasz NR, Roelfsema F, Romijn JA, Pereira AM (2008) Increased aortic root diameters in patients with acromegaly. Eur J Endocrinol 159(2):97–103
Tellatin S, Maffei P, Osto E, Dassie F, Famoso G, Montisci R, Martini C, Fallo F, Marra MP, Mioni R, Iliceto S, Vettor R, Tona F (2018) Coronary microvascular dysfunction may be related to IGF-1 in acromegalic patients and can be restored by therapy. Atherosclerosis 269:100–105
Parolin M, Dassie F, Martini C, Mioni R, Russo L, Fallo F, Rossato M, Vettor R, Maffei P, Pagano C (2018) Preclinical markers of atherosclerosis in acromegaly: a systematic review and meta-analysis. Pituitary 21(6):653–662
O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr (1999) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 340:14–22
Matsuzawa Y, Kwon TG, Lennon RJ, Lerman LO, Lerman A (2014) Prognostic value of flow-mediated vasodilation in brachial artery and fingertip artery for cardiovascular events: a systematic review and meta-analysis. J Am Heart Assoc 4:e002270
Ben-Shlomo Y, Spears M, Boustred C, May M, Anderson SG, Benjamin EJ, Boutouyrie P, Cameron J, Chen CH, Cruickshank JK, Hwang SJ, Lakatta EG, Laurent S, Maldonado J, Mitchell G, Najjar S, Newman AB, Ohishi M, Pannier B, Pereira T, Vasan RS, Shokawa T, Sutton-Tyrell K, Verbeke F, Wang KL, Webb DJ, Willum Hansen T, Zoungas S (2014) Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. J Am Coll Cardiol 63:636–646
Ritvonen E, Löyttyniemi E, Jaatinen P, Ebeling T, Moilanen L, Nuutila P, Kauppinen-Mäkelin R, Schalin-Jäntti C (2016) Mortality in acromegaly: a 20-year follow-up study. Endocr Relat Cancer 23(6):469–480
Colao A, Marzullo P, Spiezia S, Giaccio A, Ferone D, Cerbone G, Di Sarno A, Lombardi G (2000) Effect of two years of growth hormone and insulin-like growth factor-I suppression on prostate diseases in acromegalic patients. J Clin Endocrinol Metab 85(10):3754–3761
Corrêa LL, Lima GA, Paiva HB, Silva CM, Cavallieri SA, Miranda LC, Gadelha MR (2009) Prostate cancer and acromegaly. Arq Bras Endocrinol Metabol 53(8):963–968
Dal J, Leisner MZ, Hermansen K, Farkas DK, Bengtsen M, Kistorp C, Nielsen EH, Andersen M, Feldt-Rasmussen U, Dekkers OM, Sørensen HT, Jørgensen JOL (2018) Cancer incidence in patients with acromegaly: a cohort study and meta-analysis of the literature. J Clin Endocrinol Metab 103(6):2182–2188
Yamamoto M, Matsumoto R, Fukuoka H, Iguchi G, Takahashi M, NishizawaH Suda K, Bando H, Takahashi Y (2016) Prevalence of simple renal cysts in acromegaly. Intern Med 55(13):1685–1690
Auriemma RS, Galdiero M, De Martino MC, De Leo M, Grasso LF, Vitale P, Cozzolino A, Lombardi G, Colao A, Pivonello R (2010) The kidney in acromegaly: renal structure and function in patients with acromegaly during active disease and 1 year after disease remission. Eur J Endocrinol 162(6):1035–1042
Van der Valk E, Tobe T, Stades A, Muller A (2013) Vanishing hypercalciuric kidney stones after treating underlying acromegaly. Endocrinol Diabetes Metab Case Rep 2013:130001
Montini M, Gianola D, Pagani MD, Pedroncelli A, Caldara R, Gherardi F, Bonelli M, Lancranjan I, Pagani G (1994) Cholelithiasis and acromegaly: therapeutic strategies. Clin Endocrinol (Oxf) 40(3):401–406
Olarescu NC, Bollerslev J (2016) The impact of adipose tissue on insulin resistance in acromegaly. Trends Endocrinol Metab 27(4):226–237
Freda PU, Katznelson L, van der Lely AJ, Reyes CM, Zhao S, Rabinowitz D (2005) Long-acting somatostatin analog therapy of acromegaly: a meta-analysis. J Clin Endocrinol Metab 90:4465–4473
Reyes-Vidal CM, Mojahed H, Shen W, Jin Z, Arias-Mendoza F, Fernandez JC, Gallagher D, Bruce JN, Post KD, Freda PU (2015) Adipose tissue redistribution and ectopic lipid deposition in active acromegaly and effects of surgical treatment. J Clin Endocrinol Metab 100(8):2946–2955
Ciresi A, Guarnotta V, Campo D, Giordano C (2018) Hepatic steatosis index in acromegaly: correlation with insulin resistance regardless of the disease control. Int J Endocrinol 19(2018):5421961
Lee JH, Kim D, Kim HJ, Lee CH, Yang JI, Kim W, Kim YJ, Yoon JH, Cho SH, Sung MW, Lee HS (2010) Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis 42(7):503–508
Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ (2018) The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67(1):328–357
Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L (2016) American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26(1):1–133
Wolinski K, Czarnywojtek A, Ruchala M (2014) Risk of thyroid nodular disease and thyroid cancer in patients with acromegaly—meta-analysis and systematic review. PLoS One 9(2):e88787
Dogansen SC, Salmaslioglu A, Yalin GY, Tanrikulu S, Yarman S (2019) Evaluation of the natural course of thyroid nodules in patients with acromegaly. Pituitary 22(1):29–36
Reverter JL, Fajardo C, Resmini E, Salinas I, Mora M, Llatjós M, Sesmilo G, Rius F, Halperin I, Webb SM, Ricart V, Riesgo P, Mauricio D, Puig-Domingo M (2014) Benign and malignant nodular thyroid disease in acromegaly. Is a routine thyroid ultrasound evaluation advisable? PLoS One 9(8):e104174
Fonseca R, Fernández-Martínez A, Miguélez R, Uson J (2018) Ultrasound and radiographic abnormalities in a patient with chronic severe acromegaly. Reumatol Clin 14(4):236–238
Colao A, Cannavò S, Marzullo P, Pivonello R, Squadrito S, Vallone G, Almoto B, Bichisao E, Trimarchi F, Lombardi G (2003) Twelve months of treatment with octreotide-LAR reduces joint thickness in acromegaly. Eur J Endocrinol 148(1):31–38
Karkucak M, Batmaz İ, Civan N, Kilinc F, Capkin E, Sariyildiz MA, Garipŏglu MA, Onder MA, Ozcakar L (2015) Ultrasonographic measurement of femoral cartilage thickness in acromegalic patients. Clin Rheumatol 34(1):157–161
Diamond T, Nery L, Posen S (1989) Spinal and peripheral bone mineral densities in acromegaly: the effects of excess growth hormone and hypogonadism. Ann Intern Med 111(567–73):2
Ho PJ, Fig LM, Barkan AL, Shapiro B (1992) Bone mineral density of the axial skeleton in acromegaly. J Nucl Med 9:1608–1612
Gregg EW, Kriska AM, Salamone LM, Roberts MM, Anderson SJ, Ferrell RE, Kuller LH, Cauley JA (1997) The epidemiology of quantitative ultrasound: a review of the relationships with bone mass, osteoporosis and fracture risk. Osteoporos Int 7(2):89–99
Bolanowski M, Jedrzejuk D, Milewicz A, Arkowska A (2002) Quantitative ultrasound of the heel and some parameters of bone turnover in patients with acromegaly. OsteoporosInt13(4):303-8
Resmini E, Tagliafico A, Nizzo R, Bianchi F, Minuto F, Derchi L, Martinoli C, Ferone D (2009) Ultrasound of peripheral nerves in acromegaly: changes at 1-year follow-up. Clin Endocrinol (Oxf) 71(2):220–225
Sasagawa Y, Tachibana O, Doai M, Tonami H, Iizuka H (2015) Median nerve conduction studies and wrist magnetic resonance imaging in acromegalic patients with carpal tunnel syndrome. Pituitary 18(5):695–700
Tagliafico A, Resmini E, Nizzo R, Bianchi F, Minuto F, Ferone D, Martinoli C (2008) Ultrasound measurement of median and ulnar nerve cross-sectional area in acromegaly. J Clin Endocrinol Metab 93(3):905–909
Tagliafico A, Resmini E, Ferone D, Martinoli C (2011) Musculoskeletal complications of acromegaly: what radiologists should know about early manifestations. Radiol Med 116(5):781–792. https://doi.org/10.1007/s11547-011-0671-z
Staples JR, Calfee R (2017) Cubital tunnel syndrome: current concepts. J Am Acad Orthop Surg 25(10):e215–e224
Tagliafico A, Resmini E, van Holsbeeck MT, Derchi LE, Ferone D, Martinoli C (2009) Sonographic depiction of trigger fingers in acromegaly. J Ultrasound Med 28(11):1441–1446
Grynberg M, Salenave S, Young J, Chanson P (2010) Female gonadal function before and after treatment of acromegaly. J Clin Endocrinol Metab 95(10):4518–4525
Caron P, Broussaud S, Bertherat J, Borson-Chazot F, Brue T, Cortet-Rudelli C, Chanson P (2010) Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women. J Clin Endocrinol Metab 95(10):4680–4687
Kaltsas GA, Androulakis II, Tziveriotis K, Papadogias D, Tsikini A, Makras P, Dimitriou K, Stathopoulou A, Piaditis G (2007) Polycystic ovaries and the polycystic ovary syndrome phenotype in women with active acromegaly. Clin Endocrinol (Oxf) 67(6):917–922
Rosenfield RL (2007) Clinical review: Identifying children at risk for polycystic ovary syndrome. J Clin Endocrinol Metab 92(3):787–796
Unluhizarci K, Kaltsas G, Kelestimur F (2012) Non polycystic ovary syndrome-related endocrine disorders associated with hirsutism. Eur J Clin Investig 42(1):86–94
Sober AJ, Gorden P, Roth J, AvRuskin TW (1974) Visceromegaly in acromegaly. Evidence that clinical hepatomegaly or splenomegaly (but not sialomegaly) are manifestations of a second disease. Arch Intern Med 134(3):415–417
Vilar L, Vilar CF, Lyra R, Lyra R, Naves LA (2017) Acromegaly: clinical features at diagnosis. Pituitary 20(1):22–32
Dostálová S, Sonka K, Smahel Z, Weiss V, Marek J (2003) Cephalometric assessment of cranial abnormalities in patients with acromegaly. J Craniomaxillofac Surg 31(2):80–87
Greco DS (2012) Feline acromegaly. Top Companion Anim Med 27(1):31–35
Myers JA, Lunn KF, Bright JM (2014) Echocardiographic findings in 11 cats with acromegaly. J Vet Intern Med 28(4):1235–1238
Lourenço BN, Randall E, Seiler G, Lunn KF (2015) Abdominal ultrasonographic findings in acromegalic cats. J Feline Med Surg 17(8):698–703
Acknowledgements
We thank Giulia Maddalena, MD for her contribution to Fig. 1 and Dr. Marino Parolin, DVM for his contributions to the paragraphs concerning feline acromegaly. Editorial assistance for the preparation of this manuscript was provided by Alexandra Wennberg, Ph.D.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all the authors, the corresponding author states that there is no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
No informed consent.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Parolin, M., Dassie, F., Vettor, R. et al. Acromegaly and ultrasound: how, when and why?. J Endocrinol Invest 43, 279–287 (2020). https://doi.org/10.1007/s40618-019-01111-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-019-01111-9